Room Air a Safe Alternative to Dye Injection in Ureterography
Launched by ASSIUT UNIVERSITY · Oct 30, 2023
Trial Information
Current as of August 25, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a new way to perform a procedure called ureterography, which helps doctors see problems in the ureters (the tubes that carry urine from the kidneys to the bladder). Traditionally, a special dye is injected to get clear images, but this trial is investigating whether using air instead of dye can be a safe and effective alternative. This could make the procedure less invasive and possibly more affordable, as the dye can sometimes be hard to get and expensive.
Anyone who is scheduled to undergo ureteral surgery may be eligible to participate in this trial. There are no specific exclusions, which means that most patients can join. If you participate, you will receive the standard care for ureterography, but instead of dye, air will be used to help visualize your ureters. The trial aims to ensure that using air doesn’t lead to any complications, such as air bubbles in the bloodstream, while still allowing doctors to see what they need to. This could potentially change how ureterography is done in the future!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • all patients undergoing Urs
- Exclusion Criteria:
- • no
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported